Quick Summary
CBD safety, side effects, and drug interactions:
-
What is CBD?
CBD (cannabidiol) is a compound derived from hemp and marketed as a supplement despite the U.S. FDA's position that CBD is not a dietary supplement.
-
Does CBD work?
CBD taken orally has been shown to reduce the frequency of certain types of seizures, and preliminary evidence suggests it may also help with anxiety, schizophrenia, gastroparesis, and other conditions. However, most of these effects have involved large doses of CBD — hundreds of milligrams per day, which is more than in many marketed CBD supplements and products. CBD applied to the skin (such as CBD creams, gels, and lotions) may modestly reduce some forms of pain and might promote hair regrowth (see What It Is and What It Does).
-
What did CL's tests of CBD products find?
ConsumerLab found an enormous range in amounts of CBD in products -- from 5.7 mg to 240.9 mg per serving. The cost to obtain an equal amount of CBD from each product ranged from just 12 cents to $2.09 per 10 mg. Compared to CL's findings in 2018 and 2020, the price of CBD continued to fall, with the lowest cost per 10 mg of CBD now half of what it was in 2020. At the same time, the strength of products continues to increase, with many gummies, for example, now providing at 25 mg or more of CBD per serving. Levels of THC (tetrahydrocannabinol, a psychoactive compound) have tended to fall, with THC not detectable in most products. In those found to have it, the amount did not exceed 1 mg per serving — although even these lower levels can cause a positive drug test for cannabis for some people (see What CL Found, How Products Were Evaluated, and use the Results table to compare the amounts of CBD, THC, and other cannabinoids in products).
-
Best CBD?
Based on quality and value, ConsumerLab selected several Top Picks, including for CBD with THC and CBD without THC among oils, softgels, and gummies, a Top Pick among topical creams and salves, and a Top Pick for Pets.
How to choose a CBD product?
Look for CBD products that list the amount of CBD or cannabidiol per serving, and don't confuse that with the amount per entire bottle. If a product lists only "cannabinoids" it may contain some CBD but you won't know how much. Products may still have significant amounts of CBD if they list "hemp extract" as an ingredient, but don't expect much CBD if "hemp oil" is the only ingredient. Hemp extracts are more likely to contain a range of cannabinoids in addition to CBD (although it's not clear if this provides added benefit) and this is what is meant by the terms "full-spectrum" and "entourage effect" on labels — but full-spectrum products may or may not contain THC. If you want to avoid THC, look for products with claims like "THC-free" and see which products had no detectable THC in our tests. Note that CBD does not appear to be converted to THC in the body (see ConsumerTips™).
-
How much CBD should I take and when?
Most of the research with CBD has involved high doses (several hundred milligrams daily). However, many CBD products on the market are lower-dose and it is not clear if this dosing is effective. Nevertheless, to greatly increase CBD absorption, take it with or shortly after a fatty meal (see ConsumerTips: Dosage.)
- Low doses seem to be well tolerated, with abdominal discomfort being the most common side effect. High-dose CBD can cause a range of side effects (particularly gastrointestinal issues, lowered blood pressure, and increased heart rate) and can affect a wide range of medications. For details, see Concerns and Cautions.
Products tested in 2023
+— 118 sources
In addition the results of its expert testing, ConsumerLab uses only high-quality, evidence based, information sources. These sources include peer-reviewed studies and information from agencies such as the FDA and USDA, and the National Academy of Medicine. On evolving topics, studies from pre-print journals may be sourced. All of our content is reviewed by medical doctors and doctoral-level experts in pharmacology, toxicology, and chemistry. We continually update and medically review our information to keep our content trustworthy, accurate, and reliable. The following sources are referenced in this article:
- Ghovanloo, Front Physiol 2022
- Perez, Molecules 2022
- Russo, Cannabis Cannabinoid Res 2022
- Wolinsky, J Pharmacol Exp Ther 2026
- Abbassian, Br J Pharmacol 2016
- Alvarenga, J Vet Behav 2026
- Babson, Curr Psychiatry Rep 2017
- Barichello, Eur J Pharmacol 2012
- Bebee, Med J Aust 2021
- Bergamaschi, Neuropsychopharm 2011
- Bhattacharyya, JAMA Psych 2018
- Blake, Ann Palliat Med 2017
- Blake, Rheumatology (Oxford
- Boggs, Psychopharm 2018
- Capano, Postgrad Med 2019
- Carlini, J Clin Pharmacol 1981
- Chagas, J Clin Pharm Ther 2014
- Chagas, J Psychopharmacol 2014
- Consroe, Int J Neurosci 1986
- Crippa, Eur Arch Psychiatry Clin Neurosci 2019
- Crippa, JAMA Netw Open 2021
- Crippa, Neuropsychopharmacology 2004
- De Vita, Exp Clin Psychopharmacol 2021
- De Vita, JAMA Psych 2018
- Deabold, Animals (Basel
- Devinsky, New Eng J Med 2017
- Dijk, BMJ 2019
- Elms, J Altern Complement Med 2019
- Fitzcharles, Schmerz 2016
- Flint, J Anim Sci 2024
- Freeman, Lancet Psychiatry 2020
- Gamble, Front Vet Sci 2018
- Garcia, Int J Exc Sci 2019
- Giacoppo, Daru 2015
- Gournay, Psychopharmacology (Berl
- Haffar, J Arthroplasty 2022
- Hammell, Eur J Pain 2016
- Hardy, J Clin Oncol 2022
- Health Canada 2013
- Heineman, J Hand Surg 2022
- Huestis, Chem Biodivers 2007
- Hunter, Osteoarthritis Cartilage 2018
- Hurd, Am J Psychiatry 2019
- Kozela, Br J Pharmacol 2011
- Laczkovics, Neuropsychiatr 2020
- Linares, Front Pharmacol 2018
- Lopez, J Diet Suppl 2020
- Masataka, Front Psychol 2019
- McGuire, Am J Psy 2017
- Nguyen, Sci Adv 2022
- Nichols, Cannabis Cannabinoid Res 2020
- Nitecka-Buchta, J Clin Med 2019
- O'Brien, JAMA Network Open 2022
- Ramani, BBI — Integrative 2024
- Rohleder, Front Pharmacol 2016
- Roongpisuthipong, J Dermatolog Treat 2025
- Santos de Alencar, Parkinsonism Relat Disord 2021
- Shannon, Perm J 2016
- Shannon, Perm J 2019
- Smith, Cannabis 2021
- Sule-Suso, Sage Open Medical Case Reports, 2019
- Thiele, Lancet 2018
- Tomida, J Glaucoma 2006
- Vela, Pain 2021
- Verrico, Pain 2020
- Walczynska-Dragon, J Clin Med 2024
- Xu, Curr Pharm Biotechnol 2019
- Zheng, Clin Gastroentrol Hepatol 2023
- Zuardi, J Psychopharmacol 2009
- webpage
- Epidiolex Prescribing Information
- FDA 2018
- Gaddis v. Just Brands USA, Inc. et al
- Gurley, J Diet Supp 2020
- Horth, MMWR Morb Mortal Wkly Rep 2018
- Johnson, Drug Alc Depend 2022
- Johnson, J Cannabis Res 2023
- Mead, Epilepsy & Behavior 2017
- here
- list of states on ProCon.org
- Birnbaum, Epilepsia 2019
- Crippa, Cannabis Cannabinoid Res 2019
- Devinksy, Epilepsia 2014
- FDA - Epidiolex labeling revised 6/2018
- Knaub, Molecules 2019
- Merrick, Cannabis Cannabinoid Res 2016
- Brown, J Clin Med 2019
- Cortopassi, Am J Health Syst Pharm 2020
- Cáceres Guido, Epilepsia 2021
- Dahlgren, JAMA Psych 2021
- Epidiolex Prescribing Information, 3/2024
- Grayson, Epilepsy Behav Case Rep 2017
- Gustafson, Clin Chem 2003
- Iffland, Cannabis Cannabinoid Res 2017
- Jadoon, JCI Insight 2017
- Katz, JPGN Rep 2023
- Klotz, Epilepsia 2019
- Kocis, Med Cannabis Cannabinoids 2020
- Laborde-Casterot, Clin Toxicol (Phila
- Lam, Clin Toxicol 2017
- Lefebvre, J Addict Med 2024
- Leson J Anal Toxicol 2001
- National Cancer Institute 2017
- OEHHA, 8-8-22
- Pertwee, Br J Pharmacol 2008
- Pettit, Dermatitis 2018
- Prestifilippo, Exp Biol Med 2006
- Proposition 65 THC Fact Sheet
- Rianprakaisang, Clin Toxicol 2019
- Saleska, J Am Nutr Assoc 2023
- Sands, CNS Drugs 2018
- Schmitz, J Diet Supp 2020
- Shanks, J Anal Toxicol 2016
- Stott, Springerplus 2013
- Thai, Clin Pharmacol Drug Dev 2021
- U.S Department of Health
- Yamaori, Life Sci 2011
- Zamarripa, JAMA Netw Open 2023
As a ConsumerLab.com member, you may print a copy of this report for your personal use.
You can access a special print version by clicking the "Print" icon in the upper right corner of this report.
You can then use your web browser's print functions to print the whole report or just selected pages.
You may also email or post a link to this report using the web address above.
Non-members using the link will see a free summary and can join to view the full report.
Other means of copying or distributing this report, in part or full, are not permitted.
If you are sight-impaired and your computer is having trouble converting the text in this report to speech,
contact us for assistance at [email protected] or by
phone at 914-722-9149.
The "Latest Update" date indicates when new clinical or product information was most recently added. In the full review (available to CL members), the newest information is highlighted in yellow and, if a new product is added, it is footnoted in the results table, showing the date added to the review. The year(s) when testing was completed for the products in the review appears at the end of the Summary section.
|